Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

106.49
Delayed Data
As of Dec 09
 +0.83 / +0.79%
Today’s Change
92.28
Today|||52-Week Range
157.99
-31.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues671.0M759.3M862.9M950.8M
 
 
 
 
 
Cost of Goods Sold158.4M162.7M170.6M154.9M
 
 
 
 
 
Depreciation And Amortization17.8M16.6M15.8M14.8M
 
 
 
 
 
 
Operating ExpensesGross Income494.8M580.0M676.6M781.0M
 
 
 
 
 
General Expenses132.9M147.2M153.2M163.5M
 
 
 
 
 
Research And Development46.5M55.4M65.5M71.2M
 
 
 
 
 
Total Operating Expenses309.1M326.4M339.5M333.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income361.9M432.8M523.4M617.5M
 
 
 
 
 
Extraordinary Credit--0.004.2M0.00
 
 
Extraordinary Charge-33.3M-2.6M---3.0M
 
 
 
 
Interest Expense On Debt2.5M1.5M928.0K473.0K
 
 
 
 
 
Other Expenses5.8M8.5M44.4M9.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income335.9M443.9M581.7M636.8M
 
 
 
 
 
Income Taxes-67.8M-82.7M-96.1M-95.3M
 
 
 
 
 
Minority Interest-664.0K-472.0K-577.0K-339.0K
 
 
 
 
 
Discontinued Operations-1.2M-319.0K-787.0K-236.0K
 
 
 
 
 
Net Income266.2M360.4M484.3M540.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.7M44.3M42.8M42.8M
 
 
 
 
 
Shares To Calculate EPS Diluted44.7M44.3M42.8M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS$5.96$8.14$11.31$12.62
 
 
 
 
 
EPS Diluted$5.95$8.14$11.31$12.63